Back to search
FDAFDA · Food and drugs·Recall number D-0738-2026

Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68.

Published August 5, 2026 · Recall initiated: July 16, 2026

Summary

FDA records drug Class III recall D-0738-2026, published August 5, 2026 and initiated July 16, 2026. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 924 cartons x 12 x 6 x 10 (in blister pack); Lot: Lot: 25141585, Exp. April 30, 2027. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

What to do

Voluntary: Firm initiated · Letter

Get an email if DABIGATRAN ETEXILATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DABIGATRAN ETEXILATE
Manufacturer
Ascend Laboratories, LLC
Distributor
USA Nationwide
UPC
0309047253043
Lot
Lot: 25141585, Exp. April 30, 2027.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7253-68. recalled?

Yes. FDA published recall D-0738-2026 on August 5, 2026. Reported hazard: Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DABIGATRAN ETEXILATE. UPC: 0309047253043.